1. GMP Small Molecules

GMP Small molecules for Antibody-drug Conjugate(ADC)

ADC-related small molecules High purity Batch to batch consistency DMF Filing

GMP (Good Manufacturing Practice) is the fundamental principle for drug production and quality management. GMP ADC related small molecule products include ADC Payload, ADC Linker+Payload, and related intermediate. The GMP ADC related small molecule products provided by MCE strictly follow the cGMP guidelines for production, with reliable quality and high cost-effectiveness. MCE has successfully filed a series of products with the FDA, and this type of product has completed systematic and complete quality research work, supporting the declaration work and on-site audit from IND to NDA.

Cat. No. Product Name CAS No. Target

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy.

The MedChemExpress (MCE) GMP ADC-related small molecules are synthesized following ICH Q7 guidelines. Each batch of MedChemExpress (MCE) GMP small molecules has strict QC tests:

  • Purity
  • Identification
  • Water Content
  • Enantiomeric Impurity (If applicable)
  • Residual Solvent
  • Analysis of Impurities
  • Solubility
  • Others

MCE provides GMP ADC related small molecule products, and some products have already completed DMF filing, which is helpful for the development of related ADC drugs.

Name CAS Type FDA DMF Filing status
MC-Val-Cit-PAB 159857-80-4 Intermediate of MC-Val-Cit-PAB-MMAE Sec-DMF#035550
Boc-Dap-NE 160800-65-7 Intermediate of MMAE Sec-DMF#035548
Fmoc-3VVD-OH 863971-44-2 Intermediate of MMAE Sec-DMF#035549
VcMMAE 646502-53-6 Linker+Payload Sec-DMF#036740
Exatecan Mesylate 169869-90-3 Payload Sec-DMF#036708